# US 2004/0079360 A1 · Nasal inhaler

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0079360 A1
- Document ID: US20040079360A1
- Status: Published application
- Kind: A1
- Application number: 10/729,604
- Filed: 2003-12-05
- Published: 2004-04-29
- Earliest claimed: 1998-12-17
- Inventors: Ronald Alan Coffee; Alastair Bruce Pirrie; David Neville Davies
- Web page: https://patentgrep.com/patent/US20040079360A1

## CPC

- B05B 12/004: {comprising sensors for monitoring the delivery, e.g. by displaying the sensed value or generating an alarm (B05B12/08 takes precedence; registering or indicating the condition or the working of machines or other apparatus in general G07C3/00)}
- A61M 15/0066: {with means for varying the dose size}
- A61M 15/008: {Electronic counters}
- A61M 15/025: {Bubble jet droplet ejection devices}
- B05B 5/0255: {spraying and depositing by electrostatic forces only}
- B05B 5/053: Arrangements for supplying power, e.g. charging power
- B05B 5/1691: {Apparatus to be carried on or by a person or with a container fixed to the discharge device}
- B05B 12/00: Arrangements for controlling delivery; Arrangements for controlling the spray area
- A61M 2205/8206: battery-operated
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An inhaler has a housing containing a chamber (1a) providing a reservoir (8) for liquid providing an active ingredient to be supplied to a liquid outlet (10a). First and second electrodes are spaced apart (11 and 12) with the first electrode being provided at or adjacent the liquid outlet (10a). A voltage supply (5, 7) is activated in response to air flowing through an air inlet (30) of the housing to provide a potential difference between the first and second electrodes (11 and 12) to create an electric field for causing comminution of liquid issuing from the liquid supply outlet (10a) to produce a stream of electrically charged comminuted matter for supply to the nasal passages of a user via an outlet (4) of the housing.

## Claims

### Claim 1

An inhaler, comprising a housing having an outlet and an air inlet, the housing containing: liquid supply means comprising: a chamber providing a reservoir for liquid providing an active ingredient to be supplied to a user and means for supplying liquid from the reservoir to a liquid outlet; and
means for creating an electric field for causing comminution of liquid issuing from the liquid supplying means outlet in response to air flowing through the air inlet so as to produce a stream of electrically charged comminuted matter for supply to the nasal passages of the housing outlet.

### Claim 2 (depends on 1)

An inhaler according to claim 1, wherein the liquid supplying means has first and second outlets; and the electric field creating means comprises a first electrohydrodynamic comminution means for subjecting liquid issuing from the first outlet to an electrical potential to cause the liquid to be comminuted to form a comminution of one polarity; and a second electrohydrodynamic comminution means for subjecting liquid issuing from the second outlet to an electrical potential to cause the liquid to be comminuted to form a comminution of the opposite polarity, means being provided for providing an air flow to the outlet to modify any mixing of the two opposite polarity comminutions.

### Claim 3 (depends on 1)

An inhaler according to claim 1, wherein the electric field creating means comprises first and second spaced apart electrodes with the first electrode being provided at or adjacent the outlet of the liquid supplying means; and voltage supplying means operable in response to air flowing through the air inlet to provide a potential difference between the first and second electrodes.

### Claim 4 (depends on 3)

An inhaler according to claim 3, wherein the voltage supplying means comprises an air flow activated switch for coupling a voltage generating means across the first and second electrodes.

### Claim 5 (depends on 3)

An inhaler according to claim 3, wherein the air flow activated switch comprises a closure member and spring biassing means normally biassing the closure member into a position closing off the supply of air into the housing through the air inlet, the closure member being movable against the spring biassing to a position allowing air to flow into the housing through the air inlet in response to the air flow.

### Claim 6 (depends on 1, 2, 3, 4, 5)

An inhaler according to claim 1, 2, 3, 4 or 5, wherein the housing is arranged to enable a user to create the air flow by breathing in through the housing outlet.

### Claim 7

An inhaler according to any one of the preceding claims, comprising a pump for creating the air flow.

### Claim 8

An inhaler, comprising a housing having an outlet, the housing containing: a chamber providing a reservoir for liquid providing an active ingredient to be supplied to a user; means for supplying liquid from the reservoir to a liquid outlet; first and second spaced apart electrodes with the first electrode being provided at or adjacent the outlet of the liquid supplying means; and user-operable voltage supplying means for providing a potential difference between the first and second electrodes to create an electric field for causing comminution of liquid issuing from the liquid supplying means outlet to produce a stream of electrically charged comminuted matter, the first and second electrodes being spaced from the housing outlet and being arranged so as to provide, when a potential difference is applied across them by the voltage supplying means, an electric field which reduces rapidly in the direction of liquid flow from the liquid supplying means and the housing having an air flow path to the housing outlet for causing liquid comminuted by the electric field to be entrained by the air flow for supply via the housing outlet to the nasal passages of a user.

### Claim 9 (depends on 3, 5, 6, 7, 8)

An inhaler according to any one of claims 3, 5 or 8 or claims 6 and 7 when dependent on claim 3, wherein the first and second electrodes are spaced apart in a direction perpendicular to the flow of liquid from the liquid supplying means.

### Claim 10 (depends on 3, 5, 6, 7, 8, 9)

An inhaler according to any one of claims 3, 5, 8 or 9 or claims 6 and 7 when dependent on claim 3, wherein the second electrode is located downstream of the supply of liquid from the liquid outlet.

### Claim 11

An inhaler, comprising a housing having an outlet, the housing containing: a chamber providing a reservoir for liquid providing an active ingredient to be supplied to a user; means for supplying liquid from the reservoir to a liquid outlet; first and second spaced apart electrodes with the first electrode being provided at or adjacent the outlet of the liquid supplying means; and user-operable voltage supplying means for providing a potential difference between the first and second electrodes to create an electric field for causing comminution of liquid issuing from the liquid supplying means outlet to produce a stream of electrically charged comminuted matter for supply via the housing outlet to the nasal passages of a user, wherein current-limiting means are provided for limiting the supply of current by the voltage supplying means.

### Claim 12 (depends on 3, 5, 6, 7, 8)

An inhaler according to any one of claims 3, 5 or 8 or claims 6 and 7 when dependent on claim 3, wherein current-limiting means is associated with one of the first and second electrodes.

### Claim 13 (depends on 11, 12)

An inhaler according to claim 11 or 12, wherein the current-limiting means comprises a dielectric or semi-insulating coating or sleeve provided on said one of the first and second electrodes.

### Claim 14 (depends on 8, 9, 10)

An inhaler according to claim 8, 9 or 10, wherein the voltage supplying means comprises an air flow activated switch for coupling a voltage generating means across the first and second electrodes.

### Claim 15 (depends on 14)

An inhaler according to claim 14, wherein the air flow activated switch comprises a closure member and spring biassing means normally biassing the closure member into a position closing off the supply of air into the housing through the air inlet, the closure member being movable against the spring biassing to a position allowing air to flow into the housing through the air inlet in response to a user breathing in through the housing outlet or in response to an air supply to the air inlet.

### Claim 16 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

An inhaler according to any one of claims 3, 5, 8 to 15 or 6 and 7 when dependent on claim 3, wherein the voltage supplying means comprises a further electrode positioned adjacent the second electrode and resistive means coupling the second electrode to earth, the voltage supplying means being arranged to cause the further electrode to generate an ion current for charging the second electrode to an electrical potential sufficient to provide the electrical potential for causing comminution of liquid issuing from the outlet.

### Claim 17

An inhaler, comprising a housing having an outlet and an air inlet, the housing containing: a chamber providing a reservoir for liquid providing an active ingredient to be supplied to a user; means for supplying liquid from the reservoir to a liquid outlet; means for creating an electric field for causing comminution of liquid issuing from the liquid supplying means outlet; and means for providing a flow of air towards the housing outlet so as to produce a stream of electrically charged comminuted matter for supply to the nasal passages of a user via the housing outlet.

### Claim 18

An inhaler, comprising a housing having an outlet and an air inlet, the housing containing: a chamber providing a reservoir for liquid providing an active ingredient to be supplied to a user; means for supplying liquid from the reservoir to a liquid outlet; means for creating an electric field for causing comminution of liquid issuing from the liquid supplying means outlet; and means for shearing comminuted matter issuing from the liquid outlet to produce a stream of electrically charged comminuted matter of smaller size than that produced by the electric field for supply to the nasal passages of a user via the housing outlet.

### Claim 19 (depends on 18)

An inhaler according to claim 18, wherein the shearing means comprises means for producing air flow in the vicinity of liquid issuing from the liquid outlet.

### Claim 20

An inhaler comprising a housing having an outlet and an air inlet, the housing containing means for supplying liquid to first and second outlets; a first electrohydrodynamic comminution means for subjecting liquid issuing from the first outlet to an electrical potential to cause the liquid to be comminuted to form a comminution of one polarity; a second electrohydrodynamic comminution means for subjecting liquid issuing from the second outlet to an electrical potential to cause the liquid to be comminuted to form a comminution of the opposite polarity; and means for providing an air flow to the outlet to modify any mixing of the two opposite polarity comminutions.

### Claim 21 (depends on 2, 20)

An inhaler according to claim 2 or 20, wherein the air flow providing means is operable to keep the two opposite polarity comminutions apart.

### Claim 22 (depends on 2, 20, 21)

An inhaler according to claim 2, 20 or 21, further comprising means for controlling at least one of: 1) the relative flow rates of liquid to the first and second liquid outlets; 2) the relative electrical potentials to which liquid issuing from the first and second outlets is subjected; and 3) the air flow provided by the air flow providing means.

### Claim 23 (depends on 2, 20, 21, 22)

An inhaler according to claim 2, 20, 21 or 22, comprising a respective reservoir for each liquid outlet the reservoirs containing different liquids.

### Claim 24 (depends on 2, 20, 21, 22, 23)

An inhaler according to any one of claims 2, 20, 21, 22 or 23, wherein the first and second liquid outlets are angled towards one another.

### Claim 25

An inhaler according to any one of the preceding claims, further comprising air flow control valve means for controlling air flow.

### Claim 26

An inhaler comprising means for supplying liquid to a liquid outlet, voltage supply means for subjecting liquid issuing from the liquid outlet to an electric field for causing comminution of liquid issuing from the outlet, and means for controlling the size of the components, for example droplets, of the comminuted matter.

### Claim 27

An inhaler comprising means for supplying liquid to a liquid outlet, voltage supplying means for subjecting liquid issuing from the liquid outlet to an electric field for causing comminution of liquid issuing from the outlet, and means for controlling the size of the comminuted matter such that the comminuted matter has at least two different controlled sizes.

### Claim 28

An inhaler comprising means for supplying liquid to a liquid outlet, voltage supplying means for subjecting liquid issuing from the liquid outlet to an electric field for causing comminution of liquid issuing from the outlet to produce a spray of droplets, and means for controlling the diameter of the droplets so that the comminuted matter consists of droplets each having one of at least two different controlled diameters.

### Claim 29 (depends on 21, 22, 23)

An inhaler according to claim 21, 22 or 23, wherein the controlling means comprises means for superimposing on the voltage supplied by the voltage supplying means an alternating or pulsed signal.

### Claim 30 (depends on 22, 23)

An inhaler according to claim 22 or 23, wherein the controlling means comprises means for superimposing on the voltage supplied by the voltage supplying means a signal having two different frequency components for causing the comminuted matter to contain two different sizes of components.

### Claim 31 (depends on 29, 30)

An inhaler according to claim 29 or 30, wherein the superimposing means is arranged to superimpose on the voltage supplied by said voltage supplying means a signal having three or more different frequency components for causing the comminuted matter to contain three or more different sizes of components.

### Claim 32 (depends on 30, 31)

An inhaler according to claim 30 or 31, wherein said signal is arranged to consist of said frequency components superimposed simultaneously on said voltage in phase with one another.

### Claim 33 (depends on 30, 31)

A device according to claim 30 or 31, wherein said signal is arranged such that said different frequency components are superimposed one after another on said voltage.

### Claim 34 (depends on 25, 26, 27, 28, 29, 30, 31, 32)

An inhaler according to any one of claims 25 to 32, wherein the means for controlling the size of the components of the comminution comprises means for regulating the liquid flow and/or the liquid composition.

### Claim 35 (depends on 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

An inhaler according to any one of claims 25 to 34, wherein the means for controlling the size of the comminution components comprises a plurality of subsidiary liquid outlets which together form the liquid outlet and respective different cross-section supply pipes for supplying liquid to each different one of the subsidiary liquid outlets.

### Claim 36 (depends on 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

An inhaler according to any one of claims 25 to 35, wherein the means for controlling the size of the comminution components comprises a plurality of subsidiary liquid outlets which together form the liquid outlet each having a respective valve means for controlling the liquid flow from the outlet.

### Claim 37

An inhaler according to any one of the preceding claims, having a respective housing outlet for each nostril of a user or patient.

### Claim 38

An inhaler according to any combination of the preceding claims.

### Claim 39

An inhaler according to any one of the preceding claims, wherein the air flow is induced other than by inhalation.

### Claim 40

An inhaler according to any one of the preceding claims, comprising a biologically acceptable carrier for the active ingredients selected from: an oil, an alcohol, a polymer or a water-based solvent.

### Claim 41

An inhaler according to any one of the preceding claims, comprising a supply of liquid carrying as an active ingredient at least one of the following: a decongestant, a lipid, a vitamin, an antiseptic, an anti-inflammatory, an antibiotic, an anti-cancer agent, a vaccine, a protein, an enzyme, a bioadhesive, DNA or DNA fragments, nicotine and morphine.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A liquid formulation for use in an inhaler in accordance with any one of claims 1 to 38, comprising a biologically acceptable carrier liquid for an active ingredient and a polymer.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A liquid formulation for use in an inhaler in accordance with any one of claims 1 to 38, comprising a biologically acceptable carrier liquid for an active ingredient and a medium to high molecular weight polymer.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A liquid formulation for use in an inhaler in accordance with any one of claims 1 to 38, comprising a biologically acceptable carrier liquid for an active ingredient and a medium to high molecular weight polymer such as PVA or PVP.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A liquid formulation for use in an inhaler in accordance with any one of claims 1 to 38, comprising a biologically acceptable carrier liquid for an active ingredient and an amount of a polymer selected from amongst the following: 0.2 to 0.7 grammes per 10 centilitres of formulation of PVA; 0.2 grammes per 10 centilitres of formulation of PVA; from 0.2 to 1.2 grammes per 10 centilitres of formulation of PVP; or 0.5 grammes per 10 centilitres of formulation of PVP.

### Claim 46 (depends on 42, 43, 44, 45)

A liquid formulation according to claim 42, 43, 44 or 45, further comprising as an active ingredient at least one of the following: a decongestant, a lipid, a vitamin, an antiseptic, an anti-inflammatory, an antibiotic, an anti-cancer agent, a vaccine, a protein, an enzyme, a bioadhesive, DNA or DNA fragments, nicotine and morphine.

### Claim 47

A method of controlling the geometry or shape of comminuted matter produced by electrohydrodynamic comminution of at least one liquid, which method comprises controlling the geometry or shape by controlling or adjusting the amount of at least one medium to high weight polymer in the or at least one of the liquids.

### Claim 48

A method of controlling the geometry or shape of comminuted matter produced by electrohydrodynamic comminution of at least one liquid, which method comprises controlling the geometry or shape by controlling or adjusting the amount of PVA or PVP in the or at least one of the liquids.

### Claim 49

A method of controlling the geometry or shape of comminuted matter produced by electrohydrodynamic comminution of at least one liquid, which method comprises controlling the geometry or shape by adding sufficient polymer to the liquid to cause at least some of the comminuted matter to have a granular form with at least some of the granules having fibrils or tails.

### Claim 50 (depends on 47, 48, 49)

A method according to any one of claims 47 to 49, wherein the liquid comprises water and an alcohol.

### Claim 51

Use of an oil-based formulation as a carrier for an active ingredient to be delivered to a user or patient as comminuted matter formed by electrohydrodynamic comminution of the formulation.

### Claim 52

A dispensing device having liquid supply means for supplying liquid to a liquid outlet means and means for subjecting liquid issuing from the liquid outlet means to an electric field to cause electrohydrodynamic comminution of the liquid, wherein the liquid supply means comprises a supply of liquid in the form of an oil-based formulation carrying an active ingredient.

### Claim 53

A nasal inhaler having a housing containing liquid supply means for supplying liquid to a liquid outlet means and means for subjecting liquid issuing from the liquid outlet means to an electric field to cause electrohydrodynamic comminution of the liquid to provide comminuted matter to an outlet of the housing for inhalation by a user or patient, wherein the liquid supply means comprises a supply of liquid in the form of an oil-based formulation carrying an active ingredient.

### Claim 54

A delivery device having the features of the inhaler described in any one of the preceding claims but differing in that the device is arranged to supply the active ingredient to the mouth, an eye or a bodily orifice and in that air flow is induced other than by inhalation or alternatively by oral inhalation when the device is arranged to supply the active ingredient to or via the mouth.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

A method of supplying an active ingredient to the nasal passages of a human or animal which comprises using an inhaler in accordance with any one of claims 1 to 41.

### Claim 56 (depends on 54)

A method of supplying an active ingredient to an eye or bodily orifice other than the mouth or nose which comprises using a delivery device in accordance with claim 54.
